Model Evaluation of Continuous Data Pharmacometric Models: Metrics and Graphics-Reference-Cited by-同舟云学术

Model Evaluation of Continuous Data Pharmacometric Models: Metrics and Graphics

Published:2017-02 Issue:2 Volume:6 Page:87-109
ISSN:2163-8306
Container-title:CPT: Pharmacometrics & Systems Pharmacology
language:en
Short-container-title:CPT Pharmacometrics Syst. Pharmacol.

Author:

Nguyen T. H. T.¹,Mouksassi M‐S²,Holford N³,Al‐Huniti N⁴,Freedman I⁵,Hooker A. C.⁶,John J.⁷,Karlsson M. O.⁶,Mould D. R.⁸,Pérez Ruixo J. J.⁹,Plan E. L.¹⁰,Savic R¹¹,van Hasselt J. G. C.¹²,Weber B¹³,Zhou C¹⁴,Comets E¹¹⁵,Mentré F¹,

Affiliation:

1. INSERM, IAME, UMR 1137, Paris, France, Université Paris DiderotSorbonne Paris CitéParis France

2. Certara Strategic ConsultingMontréal Canada

3. Department of Pharmacology and Clinical PharmacologyUniversity of AucklandAuckland New Zealand

4. Quantitative Clinical Pharmacology, AstraZenecaWaltham Massachusetts USA

5. Dr Immanuel Freedman Inc.Harleysville Pennsylvania USA

6. Department of Pharmaceutical BiosciencesUppsala UniversityUppsala Sweden

7. Center for Drug Evaluation and Research, U.S. Food and Drug AdministrationWashington DC USA

8. Projections Research Inc.Phoenixville Pennsylvania USA

9. The Janssen Pharmaceutical Companies of Johnson & Johnson Belgium

10. PharmetheusUppsala Sweden

11. Department of Bioengineering and Therapeutic SciencesUniversity of California – San FranciscoSan Francisco California USA

12. Division of PharmacologyLeiden Academic Centre for Drug Research, Leiden UniversityLeiden Netherlands

13. Boehringer Ingelheim Pharmaceuticals, Inc.Ridgefield Connecticut USA

14. GenentechSan Francisco California USA

15. INSERM CIC 1414, Rennes, France, University Rennes‐1Rennes France

Publisher

Wiley

Subject

Pharmacology (medical),Modelling and Simulation

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/psp4.12161

Reference36 articles.

1. Basic Concepts in Population Modeling, Simulation, and Model-Based Drug Development

2. Basic Concepts in Population Modeling, Simulation, and Model-Based Drug Development-Part 2: Introduction to Pharmacokinetic Modeling Methods

3. Basic Concepts in Population Modeling, Simulation, and Model-Based Drug Development: Part 3-Introduction to Pharmacodynamic Modeling Methods

4. Prediction Discrepancies for the Evaluation of Nonlinear Mixed-Effects Models

5. Conditional Weighted Residuals (CWRES): A Model Diagnostic for the FOCE Method

Cited by 275 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A small step toward precision dosing of caffeine in preterm infants: An external evaluation of published population pharmacokinetic models;European Journal of Pharmaceutics and Biopharmaceutics;2024-11

2. Integrated Population Pharmacokinetics of Daprodustat in Patients with Chronic Kidney Disease with Anemia;Clinical Pharmacokinetics;2024-09-11

3. Investigating the Influence of Covariates on Axicabtagene Ciloleucel (axi-cel) Kinetics in Patients with Non-Hodgkin’s Lymphoma;Clinical Pharmacokinetics;2024-09-06

4. Visual predictive check of longitudinal models and dropout;Journal of Pharmacokinetics and Pharmacodynamics;2024-08-18

5. Evaluating the evidence for genotype‐informed Bayesian dosing of tacrolimus in children undergoing solid organ transplantation: A systematic literature review;British Journal of Clinical Pharmacology;2024-08-15